Feigal Ellen 4
4 · NextCure, Inc. · Filed Oct 5, 2021
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Feigal Ellen
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-10-01+28,500→ 28,500 totalExercise: $7.56Exp: 2031-09-30→ Common Stock (28,500 underlying) - Award
Stock Option (Right to Buy)
2021-10-01+10,384→ 10,384 totalExercise: $7.56Exp: 2031-09-30→ Common Stock (10,384 underlying)
Footnotes (2)
- [F1]The option vests in three equal annual installments beginning on October 1, 2021.
- [F2]The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders.